Recipharm's financial objectives

Recipharm’s objective is to be a world leading supplier of CDMO services.

The financial objectives are:  

  • Compound Annual Growth Rate (CAGR) of at least 11%, with 2019 as base year. The growth will be organic as well as come from acquisitions
  • EBITA margin of at least 12% each year, measured as profit before financial items, tax and amortisation of intangible assets attributable to acquisitions, adjusted for non-recurring items and in relation to net sales
  • A return on operating capital of 10%, defined as EBITA divided by operating capital